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CholesterolCell plasma membranes of living cells maintain their asymmetry, so that the outer leaﬂet presents a large
quantity of sphingomyelin, which is critical for formation of ordered lipid domains. Here, a recently devel-
oped probe based on Nile Red (NR12S) was applied to monitor changes in the lipid order speciﬁcally at the
outer leaﬂet of cell membranes. Important key features of NR12S are its ratiometric response exclusively to
lipid order (liquid ordered vs. liquid disordered phase) and not to surface charge, the possibility of using it
at very low concentrations (10–20 nM) and the very simple staining protocol. Cholesterol extraction, oxida-
tion and sphingomyelin hydrolysis were found to red shift the emission spectrum of NR12S, indicating a
decrease in the lipid order at the outer plasma membrane leaﬂet. Remarkably, apoptosis induced by three dif-
ferent agents (actinomycin D, camptothecin, staurosporine) produced very similar spectroscopic effects,
suggesting that apoptosis also signiﬁcantly decreases the lipid order at this leaﬂet. The applicability of NR12S
to detect apoptosis was further validated by ﬂuorescence microscopy and ﬂow cytometry, using the ratio
between the blue and red parts of its emission band. Thus, for the ﬁrst time, an environment-sensitive probe,
sensitive to lipid order, is shown to detect apoptosis, suggesting a new concept in apoptosis sensing.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cell plasma membranes exhibit remarkable asymmetry of their
bilayer leaﬂet [1,2]. Thus, while the outer leaﬂet contains large quan-
tities of sphingomyelin (SM) and phosphatidylcholine (PC), the inner
leaﬂet is characterized by signiﬁcant fractions of phosphatidylserine
(PS) and phosphatidylethanolamine (PE). This asymmetry plays an
important role for the function of membrane proteins and can partici-
pate in key processes such as apoptosis [3]. Indeed, it is well established
that apoptosis results in the exposure of PS at the outer leaﬂet, which is
responsible for the recognition of apoptotic cells by the macrophages
[4] and used for apoptosis detection [5–8]. However, it remains unclear
so far what happenswith the other lipids on apoptosis, SM in particular.
SM together with cholesterol form domains of the liquid ordered (Lo)
phase, so-called rafts, which “ﬂoat in the sea” of the liquid disordered
(Ld) phase formed by unsaturated lipids and cholesterol [9,10]. These
Lo phase domainswere hypothesized to regulate the activity of proteins
in cell plasmamembranes [11–14]. A previous work suggested that the
executive step of apoptosis is accompaniedwith the transfer of SM from
the outer to the inner leaﬂet [15]. Moreover, it has been already shown
that SM undergoes hydrolysis during apoptosis to give ceramide [16],
which produces dramatic effects on themembrane structure and prop-
erties [15]. Thus, it can be hypothesized that apoptosis should lead to
signiﬁcant changes in the lipid organization of the outer leaﬂet. Previous
early work using a ﬂuorescent membrane probe merocyanine 540: +33 368 85 43 13.
Klymchenko).
l rights reserved.showed the alternation of the “lipid packing” in apoptotic thymocytes
[17]. Later this probe was proposed as a tool for detection of apoptosis
in different cell lines [18], indicating that the changes in the “lipid pack-
ing” on apoptosis can be a rather general phenomenon. Later works
suggested that apoptosis may decrease the “lipid packing” in B lympho-
cytes [19] and increase the “interlipid spacing” in S49 Lymphoma cells
[20]. Nevertheless, these reports are scattered and it remains unclear
whether these changes are related to one or both plasma membrane
leaﬂets.
Our recent studies showed that the ﬂuorescent probe F2N12S
(Fig. 1), speciﬁc to the outer membrane leaﬂet, is able to detect apopto-
sis [21]. This is an environment-sensitive probe of 3-hydroxyﬂavone
family undergoing excited state proton transfer (ESIPT) [22,23] and is
sensitive to surface charge and hydration of lipid membranes [24,25].
Remarkably, the hydration estimated by this probe and its analogs
correlated well with the membrane phase, so that the hydration of Lo
phase is lower than that of the Ld phase [26]. This property is similar
to that of other environment-sensitive probes, such as Laurdan [10,27]
and di-ANNEPS [28,29], allowing differentiation between liquid disor-
dered and ordered phases (i.e. to sense “lipid order”) in model vesicles
[30] and cellular membranes [25]. However, as F2N12S probe was
shown to sense both lipid order and surface charge, the loss of the
lipid order as well as the exposure of PS at the outer leaﬂet could be
responsible for the probe response to apoptosis [25]. To address more
speciﬁcally the lipid order at the outer leaﬂet, without side effects of
the surface charge, we recently developed a probe NR12S (Fig. 1) [31]
based on environment-sensitive dye Nile Red [32]. NR12S binds selec-
tively at the outer membrane leaﬂet and changes its emission color in
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Fig. 1. Probes F2N12S and NR12S and their hypothetic localization with respect to
lipids in membranes.
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been successfully applied to study transmembrane asymmetry in small
and giant unilamellar vesicles [33,34]. In contrast to F2N12S, the NR12S
probe is insensitive to the surface charge, and thus enables the study of
speciﬁcally lipid order during apoptosis. In the present work, cellular
studies were performed to validate that this probe can sense lipid
order changes induced by different means: cholesterol extraction, cho-
lesterol oxidation and sphingomyelin hydrolysis. Remarkably, apoptosis,
induced by three different agents, produced very similar spectroscopic
effects, providing clear evidence that the high lipid order at the outer
leaﬂet, similar to that of Lo phase inmodel vesicles, is lost during apopto-
sis. Finally, ﬂow cytometry data showed that NR12S can be used for
quantitative detection of apoptosis in cells, similarly to the commercial
assay based on ﬂuorescently labeled annexin V [5,35].
2. Materials and methods
Probe NR12S was synthesized as described elsewhere [31].
Dioleoylphosphatidylcholine (DOPC) and cholesterol were purchased
from Sigma-Aldrich. Bovine brain sphingomyelin (SM)was fromAvanti
Polar Lipids (Alabaster, USA).
2.1. Lipid vesicles
Large unilamellar vesicles (LUVs) were obtained by the extrusion
method as previously described [36]. Brieﬂy, a suspension of multi-
lamellar vesicles was extruded by using a Lipex Biomembrane extruder
(Vancouver, Canada). The size of theﬁlterswasﬁrst 0.2 μm(7passages)
and thereafter 0.1 μm(10 passages). This generatesmonodisperse LUVs
with a mean diameter of 0.11 μm as measured with a Malvern
Zetamaster 300 (Malvern, UK). A 20 mM phosphate buffer pH 7.4 was
used in these experiments. LUVs were labeled by adding aliquots of
probe stock solutions in dimethylsulfoxide to 1 mL solutions of vesicles.
2.2. Cell lines, culture conditions and treatment
U87MG human glioblastoma cell line (ATCC) was cultured in Eagle's
minimal essential medium (EMEM from LONZA) with 10% heat-
inactivated fetal bovine serum (PAN Biotech GmbH) and 0.6 mg/mL glu-
tamine (Biowhittaker) at 37 °C in a humidiﬁed 5% CO2 atmosphere. HeLa
cells were cultured in Dulbecco's modiﬁed Eagle medium (D-MEM, high
glucose, Gibco-invitrogen) supplemented with 10% (v/v) fetal bovine
serum (FBS, Lonza), 1% antibiotic solution (penicillin–streptomycin,Gibco-invitrogen) in a humidiﬁed incubator with 5% CO2 atmo-
sphere at 37 °C. A cell concentration of 5–10×104 cells/mL was
maintained by removal of a portion of the culture and replacement
with fresh medium, three times per week.
Cholesterol depletion, cholesterol oxidation and SMase treatment
were performed using methyl-β-cyclodextrin (MβCD), cholesterol
oxidase from Streptomyces sp., and sphingomyelinase from Bacillus
cereus (Sigma-Aldrich), respectively. Brieﬂy, stock solution of MβCD
in Dulbecco's Phosphate Buffered Saline (DPBS) was prepared at a suit-
able concentration, ﬁltered byMilliporeﬁlter (0.2 μm) and added to the
cells to a ﬁnal concentration of 5 mM. The treated cells were kept at
37 °C for 2 h. For cholesterol oxidation, a stock solution of cholesterol
oxidase was prepared in 50 mM potassium phosphate buffer, pH 7.0.
The treated cells were kept at 37 °C for 2 h with 2 U/mL of cholesterol
oxidase. For SM hydrolysis, cells were incubated at 37 °C for 2 h with
0.2 U/mL of SMase.
For apoptosis studies, three different agents were tested. To in-
duce apoptotis, cells were treated with actinomycin D (0.5 μg/mL),
camptothecin (5 μg/mL), or staurosporine (0.1 μM) for 18 h at 37 °C.
In ﬂuorescence spectroscopy experiments, cells were detached by
trypsinization. The culture medium was ﬁrst removed from the cul-
ture dish and cells were washed two times with DPBS. Trypsine
10× (LONZA) solution was diluted 10 times with DPBS and added
to the cells at 37 °C for 4 min. The solution of trypsinated cells was
then diluted by HBSS (Hank's Balanced Salt Solution), transferred to
Falcon tubes and centrifuged at 1500 rpm for 5 min, two times. To
stain the cell suspension with the NR12S probe, an appropriate ali-
quot of its stock solution in DMSOwas added to 0.5 mL of HBSS buffer
and after vortexing, the solution was immediately added to 0.5 mL of
the cell suspension to obtain a ﬁnal probe concentration of 0.01 μM
(b0.25% DMSO) and a cell concentration of 1×106 cells/mL. It should
be noted that only freshly prepared solutions of the probe in HBSS
should be used (b3 min) for cell staining, because of the slow aggrega-
tion of the probe in water. Before measurements, the cell suspension
with probe was incubated for 7 min at room temperature in the dark.
For microscopy studies, cells were seeded onto a chambered cover
glass (IBiDi) at a density of 5×104 cells/IBiDi. After washing the cells
with Opti-MEM, a freshly prepared solution of NR12S in Opti-MEM was
added to the cells to a ﬁnal concentration of 0.05 μM (b0.25% DMSO
volume) and incubated for 7 min in the dark at room temperature.
2.3. Fluorescence spectroscopy and microscopy
Absorption spectra were recorded on a Cary 4 spectrophotometer
(Varian) and ﬂuorescence spectra on a FluoroMax 3.0 (Jobin Yvon,
Horiba) spectroﬂuorometer. Fluorescence emission spectra were sys-
tematically recorded at 520 nm excitation wavelength at room tem-
perature. All the spectra were corrected from the ﬂuorescence of
the corresponding blank (suspension of cells or lipid vesicles without
the probe). Fluorescence microscopy experiments were performed by
using a home-built two-photon laser scanning set-up based on an
Olympus IX70 inverted microscope with an Olympus 60× 1.2NA
water immersion objective [31]. Two-photon excitation was provided
by a titanium-sapphire laser (Tsunami, Spectra Physics) and photons
were detected with Avalanche Photodiodes (APD SPCM-AQR-14-FC,
Perkin Elmer) connected to a counter/timer PCI board (PCI6602,
National Instrument). Imaging was carried out using two fast galvo
mirrors in the descanned ﬂuorescence collection mode. Typical acqui-
sition time was 5 s with an excitation power around 4 mW (λ=
830 nm) at the sample level. Images corresponding to the green
and red channels were recorded simultaneously using a dichroic
mirror (Beamsplitter 585 DCXR), a density ﬁlter 630/30 nm and two
APDs. The images were processed with a home-made program under
LabView that generates a ratiometric image by dividing the image of
the green channel by that of the red channel. For each pixel, a
pseudo-color scale is used for coding the ratio, while the intensity is
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Fig. 2. Fluorescence of NR12S in different types of lipid vesicles. Integral ﬂuorescence inten-
sity (A) and position of the emission maximum (B) of NR12S at different concentrations in
lipid vesicles of different compositions (200 μM lipid in phosphate buffer 20 mM, pH 7.4).
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responding pixel. Both spectroscopy and microscopy measurements
were performed at 20 °C.
2.4. Flow cytometry
Cells treated with an apoptosis-inducing agent were stained using
FITC-labeled annexin V and monitored with a BD LSR II ﬂow cytometer.
For the validation of NR12S in cell cytometry, we used the same ﬂow
cytometer with a blue laser 488 nm excitation laser line with 2 emission
ﬁlters: yellow channel (PE) and red channel (PE-Texas Red). Data were
collected with the BD FACSDiva™ software and analyzed with FlowJo
(Flow Cytometer analysis software). For Flow cytometry studies, cells
were prepared with the same protocol as for ﬂuorescence spectroscopy
analysis, with 0.01 μM ﬁnal NR12S concentration. 50,000 events were
counted per sample to get enough signal.
3. Results
3.1. Optimization of the staining protocol
Initially, to ﬁnd optimal conditions at which NR12S probe binds both
Lo and Ld phases and distinguishes them by emission color, we used
model vesicles of different lipid compositions. Lipid vesicles composed
of DOPC or DOPC/cholesterol (2/1, molar ratio) represented Ld
phase [10,37,38], those composed of SM/cholesterol (2/1) — Lo phase
[39], while those composed of ternary mixture DOPC/SM/cholesterol
(1/1/1) —mixture of Lo and Ld phases [10,37,38].
Being non-ﬂuorescent in water NR12S binds all the types of lipid
vesicles at room temperature showing efﬁcient ﬂuorescence [31].
Titrations of LUVs with NR12S show that the ﬂuorescence intensity
of NR12S grows with the probe concentration and reaches a plateau
around 2 μM (Fig. 2A), which corresponds to a probe/lipid ratio of
1/100 (~1/50 taking into account only the outer membrane leaﬂet).
Partitioning of the probe into the membranes at higher probe/lipid
ratio is probably energetically not favorable, as it would disturb the
lipid bilayer structure. Moreover, at high probe concentration, self-
quenching phenomenon should take please, which is an additional
explanation for the observed saturation of the ﬂuorescence intensity.
Integral intensity of NR12S is higher in DOPC and DOPC/Chol vesicles
compared to SM/Chol, probably because of the higher afﬁnity of the
probe for the disordered Ld phase, as compared to the ordered Lo
phase. The higher lipid order of Lo phase probably decreases the
partitioning of the probe into the membrane, as commonly observed
for other membrane probes [40]. Moreover, the position of the emis-
sion maximum of NR12S in all types of lipids is red-shifted with the
increase in its concentration (Fig. 2B). This red shift indicates that at
higher concentrations, the probe molecules experience higher envi-
ronment polarity and hydration in the lipid membranes. We can spec-
ulate that at higher probe/lipid ratios the probe molecules cannot
localize at the same depth in the membrane (compared to low probe/
lipid ratios), because they would disturb the lipid bilayer, and therefore
may incorporate shallower at the membrane surface. Thus, the probe
should be used at the lowest concentration possible in order to prevent
saturation of the membranes with the probe, corresponding to its less
deﬁned shallow localization at the interface. Importantly, in the ternary
lipid mixture, the probe shows intermediate ﬂuorescence intensities
(Fig. 2A) and position of the emission maximum (Fig. 2B), indicating
that it binds both Lo and Ld phases, in line with our previous imaging
data in GUVs [31]. However, both the intensity and the position of the
maximum are much closer to those of the Ld phase, conﬁrming the
higher afﬁnity of the probe for this phase. Interestingly, at higher
probe concentrations, the observed emission maximum in ternary
mixtures is almost an average of the positions in Ld and Lo phases,
conﬁrming that at higher concentrations, NR12S incorporates shallower
into the membrane and thus stains almost equally both phases.Similar titration experiments were performed in HeLa cells. Similarly
to themodel vesicles, the emissionmaximum shows an intensity satura-
tion proﬁle and a signiﬁcant red-shift on increase in the dye concentra-
tion (Fig. S1). The red-shift is observed at lower probe concentration
than in model vesicles, indicating that saturation of the plasma mem-
branes with the probe is faster. The difference between cells and
vesicles can be explained by the lower lipid concentration in cell suspen-
sions compared to lipid vesicles. Assuming that the volume of HeLa cells
is 2.6×103 μm3 [41], the average area per lipid at the plasmamembrane
is 0.7 nm2 (0.62 nm2 for dipalmitoylphosphatidylcholine [42] and
0.72 nm2 for dioleoylphosphatidylcholine [43]), the cells are of spherical
shape in the suspension and the lipids occupy 100% of their plasma
membrane surface, we can estimate that ~1.3×109 lipid molecules are
present at the outermembrane leaﬂet of a singleHeLa cell. As the cellular
concentration in our experiments is 106 cells/mL, concentration of the
lipids at the outer leaﬂet of HeLa cells in the suspension is ~2.2 μM.
This value is slightly overestimated as some part of the plasma mem-
brane surface is taken by the membrane proteins. Nevertheless, this
rough estimation explains why at very low NR12S concentrations,
10–20 nM, corresponding to probe/lipid ratio 1/220-1/110, the emission
spectrum of NR12S is independent of its concentration (Fig. S1).
It was also found that at relatively high concentrations of NR12S, the
probe shows some phototoxicity (Fig. S2). Indeed, at 0.2 μM of NR12S,
after 30 s of exposition to light (530 nm) under an epi-ﬂuorescence mi-
croscope, HeLa cells showed dramatic changes in theirmorphology— for-
mation of bubbles within minutes followed by cell detachment from the
surface (Fig. S2B). In contrast, at 10–20 nM NR12S showed no detectable
phototoxicity (Fig. S2D). Thus, the cellular studies suggest that, the probe
should be used at rather lowconcentrations (10–20 nM) in order to avoid
artifacts related to excessive binding and photo-toxicity.
3.2. Spectroscopic effects of lipid order and apoptosis
Emission spectra of NR12S were recorded in living cells at the op-
timized low probe concentration (Fig. 3) and compared to those in
lipid vesicles of different phases. Interestingly, the position of the
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of lipid vesicles in Lo phase and to signiﬁcantly differ from the emis-
sion maximum of the ternary mixtures. Thus, the latter cannot really
model the situation in live cells, as was already noticed with the
ratiometric probe F2N12S [25].
To get further insight in the probe response to the lipid order of the
plasma membrane, the latter was modiﬁed by three different methods:
(1) cholesterol extraction by methyl-β-cyclodextrin [44], (2) cholesterol
oxidation into cholest-5-en-3-one by cholesterol oxidase [45] and (3)
sphingomyelin cleavage into ceramide by sphingomyelinase (SMase)
[46]. In the ﬁrst approach the cells were incubated with 5 mM methyl-
β-cyclodextrin for 2 h, which according to previous studies extracts 60
and 90% of the plasma membrane cholesterol from CHO [47] and aortic
endothelial cells [48], respectively [24]. In the second approach, the
cholesterol was oxidized using 2 U/mL of cholesterol oxidase for 2 h.
These conditions gave about 70% of cholesterol oxidation according to
previous data in CHO cells [49]. In the third approach, the cells were incu-
bated for 2 h with 0.2 U/mL of SMase. Previous studies on Jurkart cells
suggested that at these conditions SM content decreases by 70% and did
not change signiﬁcantly for longer incubation times [15]. In our experi-
ments with HeLa cells, all three treatments produced minor changes in
the cell morphology (sometimes cell membranes appeared smoother)
without their detachment from the surface (data not shown). All three
cell treatments shifted the emission spectrum of NR12S to the red, with
the strongest shift being observed with methyl-β-cyclodextrin (Fig. 4A).
The red shift of NR12S probe indicates increase in the polarity/hydration
of the probe environment, which based on the previous studies [31]
suggests a decrease in the lipid order (fraction of the Lo phase)
after all three treatments. To quantitatively analyze the spectral
changes of the probe, the emission spectrum was split at 585 nm
in two parts, to calculate the ratio of areas of the green to red regions
of the spectra. This approach was found to be quite sensitive, since
methyl-β-cyclodextrin was found to decrease this ratio by a factor
close to 2 (Fig. 4C).
Next, apoptosis was induced in HeLa cells by three different
agents, actinomycin D, camptothecin, staurosporine, acting by differ-
ent mechanisms. Indeed, actinomycin D inhibits DNA replication and
RNA transcription [50], camptothecin inhibits the DNA topoisomerase
I [51], while staurosporine is a protein kinase inhibitor [52]. After
incubation with these apoptosis agents, we stained cell membranes
with NR12S, and emission spectra were measured. For all three
agents, the emission maximum of NR12S spectra shifted to the red
(Fig. 4B), so that the probe detects apoptosis independently from the
type of apoptosis agent and its mechanism of action. Remarkably, the550 600 650 700
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Fig. 3. Normalized ﬂuorescence spectra of NR12S in cells and model membranes.
NR12S concentration was 0.5 μM in lipid vesicles and 0.01 μM in living cells. 200 μM
lipids in phosphate buffer 20 mM, pH 7.4 or 106 cells/ml in HBSS buffer were used.
Fig. 4. Normalized ﬂuorescence spectra of 0.01 μM NR12S in HeLa cells. (A) Intact cells
(black line), cholesterol depleted cells with methyl-β-cyclodextrin 5 mM for 2 h at
37 °C (red line), cholesterol (Chol) oxidase treated cells 2 U/mL for 2 h (green line),
and SMase treated cells 0.2 U/mL for 2 h (blue line). (B) Cells treated with different
apoptosis agents: intact cells (black line), actinomycin D 0.5 μg/mL (red line),
camptothecin 5 μg/mL (green line) and staurosporine 0.1 μM (blue line) treated cells
at 37 °C. (C) Ratiometric response of NR12S probe (green/red intensity ratio) to
modiﬁcation of the lipid composition in cell membrane and to apoptosis induction.response is similar to that observed for the decrease in the Lo phase in
model and cell membranes. Quantitative ratiometric analysis further
shows that the probe response is comparable for the three agents and
close to that observed with methyl-β-cyclodextrin, cholesterol oxidase
and SMase (Fig. 4C). The obtained results suggest that apoptosis likely
decreases the Lo phase at the outer leaﬂet. This conclusion is supported
by the previously observed increased hydration [25], increased
interlipid spacing [20] and decreased lipid packing [19], evidenced by
other membrane probes. These drastic changes in the plasma
membrane of the apoptotic cells are likely connected with the loss of
3052 Z. Darwich et al. / Biochimica et Biophysica Acta 1818 (2012) 3048–3054the transmembrane asymmetry, so that the outer leaﬂet probed by
NR12S becomes less rich in sphingolipids [15,16].
3.3. Ratiometric imaging with NR12S
Two-color ratiometric imaging was performed using two-photon
microscopy. In line with our previous studies [31], the obtained im-
ages show that the probe stains exclusively the cell membrane with
a uniform ﬂuorescence intensity ratio (Fig. 5). It can be seen from
the ratiometric images of untreated cells (Fig. 5A) that the green/
red intensity ratio is high, in corroboration with the spectroscopic
data (Fig. 3). In contrast, in cells treated with methyl-β-cyclodextrin
(Fig. 5B), we observed a decrease of the ratio, related to the shift of
NR12S spectrum to the red (Fig. 4A) [31]. In apoptotic cells treated
with actinomycin D (Fig. 5C), the green/red ratio was also decreased,
similarly to the effect of cholesterol extraction. Moreover, dramatic
changes in the morphology were observed for apoptotic cells, such
as formation of bubbles and detachment from the surface. Thus, in
line with the spectroscopic observations, the NR12S ratiometric imag-
ing shows that apoptosis leads to drastic changes in the lipid order,
which is associated with changes in the cell morphology [15,53].
3.4. NR12S versus annexin V-FITC in ﬂow cytometry
Fluorescently labeled annexin V is known as a major tool for dis-
criminating apoptotic from living cells by ﬂow cytometry [5,35].
Thus, our next step was to validate NR12S as an alternative tool in
this application. To this end, Hela cells were treated with actinomycin
D, camptothecin or staurosporine. For each condition, cells were split
into two samples; one labeled with FITC-annexin V and the second
one, labeled with NR12S. As annexin V stains only apoptotic cells,
non-treated intact cells appear essentially as a single population
with low FITC ﬂuorescence intensity (Fig. 6A). In contrast, cells treat-
ed with any of the three apoptosis-inducing agents exhibit a second
population with high FITC signal (Fig. 6B–D). The combined popu-
lation of apoptotic and dead cells was 44, 22 and 22% of total cells
(Fig S3B), for actinomycin D, camptothecin and staurosporine,
respectively.
Flow cytometry data of NR12S-labeled cells are presented in a
bi-parametric form: red channel versus green channel (Fig. 6E–H).
While mainly one population was observed with intact cells, two dis-
tinct populations were observed when apoptosis was induced. The
new population, which exhibits a lower green/red ratio can be readily
assigned to the combined population of apoptotic and dead cells, sim-
ilarly to color changes observed from spectroscopy and microscopy
data. Remarkably, the new population represented 47, 22 and 21%
of total cells for actinomycin D, camptothecin and staurosporine, re-
spectively, in good accordance with the FITC-Annexin V data (Fig.A
Fig. 5. Fluorescence ratiometric images of HeLa cells stained with NR12S. (A) Intact cells (B) ch
0.5 μg/mL actinomycine D for 18 h at 37 °C. NR12S concentration was 0.05 μM.S3B). Thus, the response of NR12S to apoptosis correlates well with the
response of ﬂuorescently labeled annexin V assay, so that NR12S could
be used as for apoptosis detection by ﬂow cytometry. The advantage of
this probe with respect to Annexin V is themuch simpler and faster pro-
tocol of cell staining. This dye could also be compared to F2N12S, a
recently developed ratiometric probe of the 3-hydroxychromone family
[21]. The advantage of NR12S is its red-shifted absorption and emission
so that it can be used at signiﬁcantly lower concentrations (10 nM)
due to the lower contribution of cell auto-ﬂuorescence at these wave-
lengths. Compared to merocyanine 540 [17,18], NR12S can be used
at >1000 times lower concentrations (10–20 nM NR12S vs 30 μM
merocyanine 540 [18]) and its response to apoptosis is ratiometric
(i.e. color response) in contrast to the intensiometric response of
merocyanine 540.
4. Conclusions
A recently developed ﬂuorescent membrane probe NR12S based
on Nile Red was applied to monitor changes in the lipid order at the
outer leaﬂet of cell plasma membranes. This probe changes its emis-
sion color in response to lipid order (liquid ordered vs. liquid disor-
dered phase) and can be used at concentrations as low as 10 nM.
We showed that cholesterol extraction and oxidation as well as
sphingomyelin hydrolysis produce a red-shift in the emission spec-
trum of NR12S, indicating that the probe can sense the decrease
in the lipid order at the outer plasma membrane leaﬂet. Remarkably,
apoptosis induced by three different agents (actinomycin D, camp-
tothecin, staurosporine) produced very similar spectroscopic effects,
suggesting that apoptosis also signiﬁcantly decreases the lipid order
at this leaﬂet. The loss of lipid order on apoptosis is probably
connected with sphingomyelin hydrolysis and lipid scrambling at its
executive step, leading to a ﬂux of sphingomyelin/ceramide from
the outer to the inner leaﬂet [15,16]. The applicability of NR12S to de-
tect apoptosis was validated using also ﬂuorescence microscopy and
ﬂow cytometry, where the signal was recorded as a ratio between
the blue and red parts of its emission band. Thus, using the recently
developed NR12S probe, we show a connection between apoptosis
and the decrease in the lipid order at the outer plasma membrane
leaﬂet, which suggests a new concept in apoptosis detection based
on environment-sensitive dyes.
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Fig. 6. Flow cytometry data for intact and apoptotic HeLa cells using FITC-annexin V (A–D) and NR12S probe (E–H). (A,E) Intact cells (B,F) actinomycin D treated cells (C,G)
camptothecin treated cells and (D,H) staurosporine treated cells. Cells treated with apoptosis agents showed two populations: intact cells with low FITC signal, and apoptotic
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show two populations differing by the ratio of their intensities in the green and red channels: intact cells with high green/red ratios and apoptotic+dead cells with low green/red
ratios.
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